Oscar Health (NYSE:OSCR) Stock Price Down 7.2% – What’s Next?

Oscar Health, Inc. (NYSE:OSCR) shares dropped 7.2% during trading on Friday. The stock traded as low as $31.20 and last traded at $30.9260. Approximately 2,083,722 shares were traded during trading, a decline of 69% from the average session volume of 6,762,301 shares. The stock had previously closed at $33.32.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Wells Fargo & Company boosted their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Barclays lifted their price objective on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, September 17th. Weiss Ratings upgraded Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Finally, Robert W. Baird boosted their price objective on Oscar Health from $27.00 to $33.00 and gave the stock a “neutral” rating in a research report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $34.90.

Oscar Health Trading Down 7.0%

The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market cap of $9.56 billion, a P/E ratio of 22.14, a P/E/G ratio of 0.34 and a beta of 2.47. The firm has a 50 day simple moving average of $31.78 and a 200 day simple moving average of $27.35.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter in the previous year, the company earned ($0.89) earnings per share. Oscar Health’s revenue for the quarter was up 70.4% on a year-over-year basis. On average, equities research analysts predict that Oscar Health, Inc. will post 1.83 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Richard Blackley sold 28,869 shares of Oscar Health stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $907,930.05. Following the completion of the sale, the chief financial officer owned 1,046,108 shares of the company’s stock, valued at approximately $32,900,096.60. This trade represents a 2.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 31,422 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $988,221.90. Following the completion of the sale, the director directly owned 449,444 shares in the company, valued at approximately $14,135,013.80. The trade was a 6.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 874,451 shares of company stock valued at $26,761,671 in the last ninety days. 22.64% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Financial Management Professionals Inc. bought a new stake in Oscar Health during the third quarter worth about $26,000. CoreCap Advisors LLC boosted its holdings in shares of Oscar Health by 526.3% in the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock worth $34,000 after purchasing an additional 1,000 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Oscar Health by 32.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after purchasing an additional 357 shares during the last quarter. FNY Investment Advisers LLC bought a new position in shares of Oscar Health during the 2nd quarter valued at about $57,000. Finally, Allworth Financial LP raised its holdings in shares of Oscar Health by 124.9% during the 2nd quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock valued at $58,000 after buying an additional 1,128 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.